2015~2018 年广东省医药产业市场绩效分析【摘要】市场绩效是 SCP 行业分析的最后一个环节,本文针对广东省医药产业进行市场绩效研究,分析 2015~2018 年广东省医药产业在特定的市场结构和市场行为条件下的经济运行情况。目前,广东省响应国家号召和实践广东发展先驱力量,医药产业蓬勃发展,供给侧改革更在加紧进行。2018 年度,我国仿制药一致性评价、4+7 集中采购、两票制和减费降税系列政策飞速推进,为广东省深化医药卫生体制改革谋策出力,在几近重建医药产业市场构架的同时也打破了原有市场平衡与企业协调情况,加快了市场绩效的波动和变化,对产业经济形成了多方面影响。本研究即是为了测度相关绩效指标,分析当前市场运行的经济效果而展开。本文采用的市场绩效分析方式是统计研究及利润率指标分析,通过整理 2015~2018 年国家统计局、广东统计年鉴、中商产业研究院相关数据,以广东省医药制造业规模以上工业为研究主体,对广东省医药产业运行情况进行分析,衡量 4 年间医药产业市场绩效的变化,最后作出对于国家产业延伸、广东省医药产业发展和企业个体发展的相关建议。【关键词】SCP;市场绩效;医药产业;利润率;供给侧改革Market performance analysis of Guangdong pharmaceutical industry in 2015-2018[Abstract]Market performance is the last link of SCP industry analysis. This paper studies the market performance of Guangdong pharmaceutical industry and analyzes the economic operation of Guangdong pharmaceutical industry in 2015-2018 under the specific market structure and market behavior conditions. At present, Guangdong Province responds to the call of the state and practices the pioneering force of Guangdong's development, the pharmaceutical industry is booming, and the supply side reform is stepping up. In 2018, China's generic drug consistency evaluation, 4 + 7 centralized procurement, two vote system and tariff reduction and tax reduction policies were carried out at full speed, contributing to the deepening of the reform of the medical and health system in Guangdong Province. While nearly rebuilding...